Coupang, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports the results of Coupang, Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders representing approximately 91.2% of the voting power (5,677,920,671 votes) were present, constituting a quorum. All three proposals were approved:
- Director Elections: All eight nominees were elected to serve until the 2027 annual meeting. The highest "Against" vote was received by Ambereen Toubassy (184,685,050 votes), while Neil Mehta received the fewest "Against" votes (10,472,310).
- Auditor Ratification: Samil PricewaterhouseCoopers was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,651,854,104 votes in favor.
- Executive Compensation: The advisory vote on named executive officer compensation was approved with 5,489,926,819 votes in favor.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the final vote tallies from the Annual Meeting.
Key Facts for Investor Verification
- Verify the full list of director nominees and their individual vote counts in the definitive proxy statement filed on April 27, 2026.
- Confirm the specific compensation details for named executive officers referenced in the advisory vote.
- Note the significant number of broker non-votes (84,012,790) recorded for the director elections and executive compensation proposal.
- Review the supplement to the Proxy Statement filed on May 18, 2026, for any additional context regarding the proposals.